Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CONIFER (Characterization of NSAID Intake for Established Rheumatoid Arthritis)

Trial Profile

CONIFER (Characterization of NSAID Intake for Established Rheumatoid Arthritis)

Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2018

At a glance

  • Drugs Tocilizumab (Primary) ; Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms CONIFER
  • Sponsors Roche
  • Most Recent Events

    • 22 Oct 2018 Status changed from active, no longer recruiting to completed.
    • 10 Jan 2018 Status changed from recruiting to active, no longer recruiting.
    • 18 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top